简体中文
繁體中文
English
Pусский
日本語
ภาษาไทย
Tiếng Việt
Bahasa Indonesia
Español
हिन्दी
Filippiiniläinen
Français
Deutsch
Português
Türkçe
한국어
العربية
Abstract:LONDON (Reuters) – Philip Morris‘ $16 billion offer for Stockholm-based Swedish Match represents a “healthy premium” and the Marlboro maker could yet go higher, Swedish Match’s No. 10 shareholder GACMO Investors said on Thursday.
div classBodysc17zpet90 cdBBJodivpLONDON Reuters – Philip Morris‘ 16 billion offer for Stockholmbased Swedish Match represents a “healthy premium” and the Marlboro maker could yet go higher, Swedish Match’s No. 10 shareholder GACMO Investors said on Thursday.p
pMarlboro maker Philip Morris agreed on Wednesday to buy Swedish Match, one of the worlds biggest makers of oral nicotine products. These include Snus – a sucked tobacco product the firm says is less harmful than smoking – as well as Zyn nicotine pouches, which are used the same way and tobaccofree.pdivdivdiv classBodysc17zpet90 cdBBJodiv
pKevin Dreyer, cochief investment officer, value, at GAMCO identified Japan Tobacco Inc JTI as a possible rival bidder but said it would be hardpressed to hijack the deal. GAMCO, formerly known as Gabelli Asset Management Company, owns just over 2 of Swedish Match, according to Refinitiv.p
p“PMI has very deep pockets and will be a tough company to outbid,” he said. “This deal is really the culmination of the last fivetoseven years of work Swedish Match has done in developing Zyn into the leading brand, and having that advantageous market share – its an attractive stock.”p
pPhilip Morris declined to comment. Swedish Match and JTI did not immediately respond to a request for comment.p
pPhilip Morris needs at least 90 of shareholders to approve the deal for it to succeed. Some other shareholders have questioned whether the Philip Morris offer represents good value. Swedish Match shareholder Bronte Capital said on Wednesday the price Philip Morris agreed to pay was “unacceptable”.p
p
pp Reporting by Richa Naidu editing by David Evans and Emelia SitholeMatarisep
divdivdiv classBodysc17zpet90 cdBBJodivdivdiv
Disclaimer:
The views in this article only represent the author's personal views, and do not constitute investment advice on this platform. This platform does not guarantee the accuracy, completeness and timeliness of the information in the article, and will not be liable for any loss caused by the use of or reliance on the information in the article.